Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB)

NCT02620410 is registered in ClinicalTrials.gov with Axonics, Inc. as lead sponsor.

NCT NCT02620410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02620410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB)
Lead sponsor
Axonics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2016
Completion date
January 31, 2022
Enrollment
51 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder